Reports for GE HEALTHCARE CANADA INC
Company Name
GE HEALTHCARE CANADA INC
Totals |
||
Shortage reports |
59 |
|
| Actual shortage: | 4 (7%) | |
| Anticipated shortage: | 15 (25%) | |
| Avoided shortage: | 3 (5%) | |
| Resolved: | 37 (63%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
2 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OMNIPAQUE 240 | 518MG | SOLUTION | Anticipated shortage | 2022-05-13 | 2022-05-13 | 160531 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2021-08-18 | 2021-08-25 | 144299 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Resolved | 2022-04-01 | 2022-04-19 | 157813 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Actual shortage | 2022-05-12 | 2022-05-13 | 160389 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Anticipated shortage | 2022-05-13 | 2022-05-13 | 160534 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Anticipated shortage | 2022-05-13 | 2022-05-13 | 160537 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Anticipated shortage | 2022-05-13 | 2022-05-13 | 160540 |
| OMNIPAQUE 300 | 647MG | SOLUTION | Actual shortage | 2022-05-13 | 2022-05-14 | 160562 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2021-08-06 | 2021-08-13 | 143789 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Resolved | 2022-04-11 | 2022-04-22 | 158491 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Anticipated shortage | 2022-05-13 | 2022-05-13 | 160543 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Anticipated shortage | 2022-05-13 | 2022-05-13 | 160546 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Anticipated shortage | 2022-05-13 | 2022-05-13 | 160549 |
| OMNIPAQUE 350 | 755MG | SOLUTION | Anticipated shortage | 2022-05-13 | 2022-05-13 | 160552 |
| OMNISCAN | 287MG | SOLUTION | Resolved | 2019-09-10 | 2019-09-17 | 93472 |
| OMNISCAN | 287MG | SOLUTION | Resolved | 2019-09-24 | 2019-11-01 | 94587 |
| OMNISCAN | 287MG | SOLUTION | Resolved | 2019-10-11 | 2019-11-06 | 96322 |
| OMNISCAN | 287MG | SOLUTION | Resolved | 2021-01-29 | 2021-05-29 | 132721 |
| OMNISCAN | 287MG | SOLUTION | Resolved | 2021-02-17 | 2021-03-13 | 134259 |
| OMNISCAN | 287MG | SOLUTION | Resolved | 2021-04-09 | 2021-05-01 | 137283 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| Metastron | 37 MBq/mL | Solution | Discontinued | 2018-10-12 | 2019-02-01 | 63929 |
| THALLOUS CHLORIDE TI 201 INJECTION | 37MBq | SOLUTION | Discontinued | 2020-12-04 | 2021-06-05 | 129592 |
Showing 1 to 2 of 2